<?xml version='1.0' encoding='UTF-8'?>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Mult Scler</journal-id>
      <journal-id journal-id-type="iso-abbrev">Mult Scler</journal-id>
      <journal-id journal-id-type="publisher-id">MSJ</journal-id>
      <journal-id journal-id-type="hwp">spmsj</journal-id>
      <journal-title-group>
        <journal-title>Multiple Sclerosis (Houndmills, Basingstoke, England)</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1352-4585</issn>
      <issn pub-type="epub">1477-0970</issn>
      <publisher>
        <publisher-name>SAGE Publications</publisher-name>
        <publisher-loc>Sage UK: London, England</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">34259578</article-id>
      <article-id pub-id-type="pmc">8961247</article-id>
      <article-id pub-id-type="doi">10.1177/13524585211030212</article-id>
      <article-id pub-id-type="publisher-id">10.1177_13524585211030212</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Research Papers</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Functional connectivity in multiple sclerosis modelled as connectome
stability: A 5-year follow-up study</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8446-2111</contrib-id>
          <name>
            <surname>Høgestøl</surname>
            <given-names>Einar August</given-names>
          </name>
          <xref rid="fn1-13524585211030212" ref-type="author-notes">*</xref>
          <xref rid="corresp1-13524585211030212" ref-type="corresp"/>
          <aff id="aff1-13524585211030212">“Department of Neurology, Neuroscience Research
Unit, Multiple Sclerosis Research Group University of Oslo &amp; Oslo
University Hospital; Institute of Clinical Medicine, University of Oslo,
Oslo, Norway</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ghezzo</surname>
            <given-names>Samuele</given-names>
          </name>
          <xref rid="fn1-13524585211030212" ref-type="author-notes">*</xref>
          <aff id="aff2-13524585211030212">NORMENT, Division of Mental Health and
Addiction, Oslo University Hospital, Oslo, Norway/Department of
Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nygaard</surname>
            <given-names>Gro Owren</given-names>
          </name>
          <aff id="aff3-13524585211030212">Department of Neurology, Neuroscience Research
Unit, Multiple Sclerosis Research Group University of Oslo &amp; Oslo
University Hospital, Oslo, Norway</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Espeseth</surname>
            <given-names>Thomas</given-names>
          </name>
          <aff id="aff4-13524585211030212">Department of Psychology, University of Oslo,
Oslo, Norway; Bjørknes College, Oslo, Norway</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sowa</surname>
            <given-names>Piotr</given-names>
          </name>
          <aff id="aff5-13524585211030212">Division of Radiology and Nuclear Medicine,
Oslo University Hospital, Oslo, Norway</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Beyer</surname>
            <given-names>Mona K</given-names>
          </name>
          <aff id="aff6-13524585211030212">Institute of Clinical Medicine, University of
Oslo, Oslo, Norway/Division of Radiology and Nuclear Medicine, Oslo
University Hospital, Oslo, Norway</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Harbo</surname>
            <given-names>Hanne Flinstad</given-names>
          </name>
          <aff id="aff7-13524585211030212">“Department of Neurology, Neuroscience Research
Unit, Multiple Sclerosis Research Group University of Oslo &amp; Oslo
University Hospital; Institute of Clinical Medicine, University of Oslo,
Oslo, Norway</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Westlye</surname>
            <given-names>Lars T</given-names>
          </name>
          <aff id="aff8-13524585211030212">NORMENT, Division of Mental Health and
Addiction, Oslo University Hospital, Oslo, Norway/Department of Psychology,
University of Oslo, Oslo, Norway/KG Jebsen Centre for Neurodevelopmental
Disorders, University of Oslo, Oslo, Norway</aff>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5039-1359</contrib-id>
          <name>
            <surname>Hulst</surname>
            <given-names>Hanneke E</given-names>
          </name>
          <aff id="aff9-13524585211030212">Department of Neuroscience, Vrije Universiteit
Amsterdam, Amsterdam, The Netherlands/Department of Anatomy and
Neurosciences, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC,
Amsterdam, The Netherlands</aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alnæs</surname>
            <given-names>Dag</given-names>
          </name>
          <aff id="aff10-13524585211030212">NORMENT, Division of Mental Health and
Addiction, Oslo University Hospital, Oslo, Norway; Bjørknes College, Oslo,
Norway</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <corresp id="corresp1-13524585211030212">EA Høgestøl Department of Neurology,
Neuroscience Research Unit, Multiple Sclerosis Research Group University of Oslo
&amp; Oslo University Hospital, Domus Medica 4, Room L-268, Gaustadalleén 34,
0372 Oslo, Norway. <email>einar.august@gmail.com</email></corresp>
        <fn fn-type="equal" id="fn1-13524585211030212">
          <label>*</label>
          <p>Einar August Høgestøl and Samuele Ghezzo contributed equally to this work as
first authors.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>14</day>
        <month>7</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>4</month>
        <year>2022</year>
      </pub-date>
      <volume>28</volume>
      <issue>4</issue>
      <fpage>532</fpage>
      <lpage>540</lpage>
      <history>
        <date date-type="received">
          <day>27</day>
          <month>2</month>
          <year>2021</year>
        </date>
        <date date-type="rev-recd">
          <day>10</day>
          <month>6</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>6</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© The Author(s), 2021</copyright-statement>
        <copyright-year>2021</copyright-year>
        <copyright-holder content-type="sage">SAGE Publications</copyright-holder>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This article is distributed under the terms of the Creative Commons
Attribution 4.0 License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>) which permits
any use, reproduction and distribution of the work without further
permission provided the original work is attributed as specified on the SAGE
and Open Access pages (<ext-link ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p>
        </license>
      </permissions>
      <abstract>
        <sec id="section1-13524585211030212">
          <title>Background:</title>
          <p>Brain functional connectivity (FC) in multiple sclerosis (MS) is abnormal
compared to healthy controls (HCs). More longitudinal studies in MS are
needed to evaluate whether FC stability is clinically relevant.</p>
        </sec>
        <sec id="section2-13524585211030212">
          <title>Objective:</title>
          <p>To compare functional magnetic resonance imaging (fMRI)-based FC between MS
and HC, and to determine the relationship between longitudinal FC changes
and structural brain damage, cognitive performance and physical
disability.</p>
        </sec>
        <sec id="section3-13524585211030212">
          <title>Methods:</title>
          <p>T1-weighted MPRAGE and resting-state fMRI (1.5T) were acquired from 70
relapsing-remitting MS patients and 94 matched HC at baseline (mean months
since diagnosis 14.0 ± 11) and from 60 MS patients after 5 years.
Independent component analysis and network modelling were used to measure
longitudinal FC stability and cross-sectional comparisons with HC. Linear
mixed models, adjusted for age and sex, were used to calculate
correlations.</p>
        </sec>
        <sec id="section4-13524585211030212">
          <title>Results:</title>
          <p>At baseline, patients with MS showed FC abnormalities both within networks
and in single connections compared to HC. Longitudinal analyses revealed
functional stability and no significant relationships with clinical
disability, cognitive performance, lesion or brain volume.</p>
        </sec>
        <sec id="section5-13524585211030212">
          <title>Conclusion:</title>
          <p>FC abnormalities occur already at the first decade of MS, yet we found no
relevant clinical correlations for these network deviations. Future
large-scale longitudinal fMRI studies across a range of MS subtypes and
outcomes are required.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Multiple sclerosis</kwd>
        <kwd>neuroimaging</kwd>
        <kwd>functional neuroimaging</kwd>
        <kwd>connectome</kwd>
        <kwd>cohort studies</kwd>
        <kwd>longitudinal studies</kwd>
        <kwd>neuropsychological tests</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>typesetter</meta-name>
          <meta-value>ts1</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="section6-13524585211030212">
      <title>Introduction</title>
      <p>Multiple sclerosis (MS) is a disease characterized radiologically by the accumulation
of lesions in white and grey matter over time throughout the central nervous system
(CNS).<sup><xref rid="bibr1-13524585211030212" ref-type="bibr">1</xref>,<xref rid="bibr2-13524585211030212" ref-type="bibr">2</xref></sup>
The white matter of the brain constitutes a framework for structural connectivity
between brain regions, supporting large-scale brain functional network
connectivity,<sup><xref rid="bibr3-13524585211030212" ref-type="bibr">3</xref><xref rid="bibr4-13524585211030212" ref-type="bibr"/>–<xref rid="bibr5-13524585211030212" ref-type="bibr">5</xref></sup> collectively
termed the functional connectome. Accumulating evidence has demonstrated abnormal
patterns of brain functional connectivity (FC) in MS patients as compared to healthy
controls (HCs).<sup><xref rid="bibr4-13524585211030212" ref-type="bibr">4</xref>,<xref rid="bibr6-13524585211030212" ref-type="bibr">6</xref><xref rid="bibr7-13524585211030212" ref-type="bibr"/><xref rid="bibr8-13524585211030212" ref-type="bibr"/><xref rid="bibr9-13524585211030212" ref-type="bibr"/><xref rid="bibr10-13524585211030212" ref-type="bibr"/><xref rid="bibr11-13524585211030212" ref-type="bibr"/>–<xref rid="bibr12-13524585211030212" ref-type="bibr">12</xref></sup> While extensive evidence
shows that FC abnormalities are associated with clinical disability in MS,<sup><xref rid="bibr4-13524585211030212" ref-type="bibr">4</xref>,<xref rid="bibr6-13524585211030212" ref-type="bibr">6</xref><xref rid="bibr7-13524585211030212" ref-type="bibr"/><xref rid="bibr8-13524585211030212" ref-type="bibr"/><xref rid="bibr9-13524585211030212" ref-type="bibr"/>–<xref rid="bibr10-13524585211030212" ref-type="bibr">10</xref>,<xref rid="bibr12-13524585211030212" ref-type="bibr">12</xref></sup> there is a complex pattern of
increased and decreased connectivity, both between brain regions directly affected
by lesions, as well as putative secondary cascade effects in distal brain regions.<sup>
<xref rid="bibr4-13524585211030212" ref-type="bibr">4</xref>
</sup> In addition, the heterogeneity across patients in lesions location is likely
to further contribute to individual differences in FC aberrations in MS.<sup><xref rid="bibr4-13524585211030212" ref-type="bibr">4</xref>,<xref rid="bibr13-13524585211030212" ref-type="bibr">13</xref></sup></p>
      <p>The complex interplay between FC dysregulation and clinical impairment cannot be
reduced to the effects of local FC increase or decrease in a cross-sectional
setting.<sup><xref rid="bibr4-13524585211030212" ref-type="bibr">4</xref>,<xref rid="bibr13-13524585211030212" ref-type="bibr">13</xref></sup> A longitudinal, individual-based and connectome-wide approach
that accounts for FC stability following structural damage is warranted to better
understand the complex interplay between brain lesions, disease progression and
heterogeneous FC aberrations in MS.<sup><xref rid="bibr4-13524585211030212" ref-type="bibr">4</xref>,<xref rid="bibr13-13524585211030212" ref-type="bibr">13</xref><xref rid="bibr14-13524585211030212" ref-type="bibr"/>–<xref rid="bibr15-13524585211030212" ref-type="bibr">15</xref></sup> This can be conceptualized as
connectome stability, where the instability could refer to both compensatory ‘good’
changes, and aberrant connectivity caused by lesions giving rise to disorganization
in FC (like maladaptation).<sup>
<xref rid="bibr16-13524585211030212" ref-type="bibr">16</xref>
</sup></p>
      <p>Here, we investigated a prospectively collected MS cohort with comprehensive imaging
and clinical data over 5 years. First, we compared baseline resting-state functional
magnetic resonance imaging (rs-fMRI) in MS patients to a group of age and
sex-matched HC. Second, we used longitudinal rs-fMRI data from the patients to
compute regional and global indices of longitudinal connectome stability.<sup>
<xref rid="bibr16-13524585211030212" ref-type="bibr">16</xref>
</sup> This measure reduces complex connectome-wide changes into a single,
individual-level marker of longitudinal FC stability. We investigated the clinical
relevance of the FC-stability measure through linear associations with disease
progression, brain volume, lesion load, and clinical and cognitive outcomes. Our
hypotheses were (1) MS affects fMRI-based FC in the first decade of disease, as
compared with HC, (2) FC stability over a 5-year interval is related to fewer
structural changes in patients and (3) FC stability is related to better cognitive
and physical disability in MS.</p>
    </sec>
    <sec sec-type="materials|methods" id="section7-13524585211030212">
      <title>Material and methods</title>
      <sec id="section8-13524585211030212">
        <title>Participants</title>
        <p>The 76 MS patients were part of a prospective longitudinal MS study at the Oslo
University Hospital.<sup>
<xref rid="bibr17-13524585211030212" ref-type="bibr">17</xref>
</sup> All patients were diagnosed between January 2009 and October 2012 with
relapsing-remitting multiple sclerosis (RRMS),<sup>
<xref rid="bibr18-13524585211030212" ref-type="bibr">18</xref>
</sup> with one patient later re-evaluated to be primary-progressive (PP)
multiple sclerosis. Five years after baseline, 62 patients were re-examined. Six
and two MS patients were not examined with rs-fMRI sequence at baseline and
follow-up, respectively. For all the inclusion criteria, please refer to
<ext-link xlink:href="http://journals.sagepub.com/doi/suppl/10.1177/13524585211030212" ext-link-type="uri">Supplemental Data</ext-link>.</p>
        <p>We included cross-sectional data from 94 age and sex-matched HC participants from
the Norwegian Cognitive NeuroGenetics (NCNG) cohort, recruited through newspaper advertisements.<sup>
<xref rid="bibr19-13524585211030212" ref-type="bibr">19</xref>
</sup> Inclusion criteria were age between 20 and 80 years, no previous diseases
affecting the CNS, no previous psychiatric disorders and no previous or current
substance abuse.</p>
        <p>The project was approved by the regional ethical committee of South Eastern
Norway (REC ID: 2011/1846, 2016/102 and 2009/2070), and all participants
received oral and written information and gave their written informed
consent.</p>
      </sec>
      <sec id="section9-13524585211030212">
        <title>Neurological and cognitive assessment</title>
        <p>All MS patients completed a comprehensive neurological examination at baseline
and follow-up, including assessment of the Expanded Disability Status Scale
(EDSS), Timed 25-Foot Walk (T25-FW) and the nine-hole peg test (9HPT) within the
same week as the MRI scan. No evidence of disease activity (NEDA) was defined as
the absence of clinical relapses, new or enlarging MRI lesions, new gadolinium
(Gd)-enhancing lesions and EDSS progression.</p>
        <p>Furthermore, all participants completed a comprehensive cognitive evaluation with BICAMS<sup>
<xref rid="bibr20-13524585211030212" ref-type="bibr">20</xref>
</sup> and some additional tests (<ext-link xlink:href="http://journals.sagepub.com/doi/suppl/10.1177/13524585211030212" ext-link-type="uri">Supplementary Table 1</ext-link>), evaluating the cognitive domains of:
processing speed, executive functioning, visuospatial and verbal memory. To
minimize practice-related effects, we used validated subtests whenever possible.
For cognitive tests for HC, please refer to <ext-link xlink:href="http://journals.sagepub.com/doi/suppl/10.1177/13524585211030212" ext-link-type="uri">Supplemental Data</ext-link>.</p>
        <p>In order to obtain measures of cognition, we first calculated
<italic toggle="yes">Z</italic>-scores for each of the tests administered using the average
performance, and standard deviation, of matched HC at baseline as a reference.
We then grouped the <italic toggle="yes">Z</italic>-scores into the four domains previously
described and averaged them within each domain, obtaining a domain-specific
measure of cognition at the patient level. Finally, we averaged the scores
across the four domains, obtaining a measure of overall cognition for each MS
patient at both time points. Similarly, we averaged the
<italic toggle="yes">Z</italic>-scores for T25-FW and 9HPT to obtain a measure of physical
ability for the MS subjects, both at baseline and follow-up. Since measures of
physical ability for HC were missing, we used the average performance, and
standard deviation, of the patient cohort itself as reference to calculate the
<italic toggle="yes">Z</italic>-scores for physical ability.</p>
      </sec>
      <sec id="section10-13524585211030212">
        <title>MRI acquisition and structural MRI pre- and post-processing</title>
        <p>All MS and HC participants were scanned using the same 1.5T scanner (Avanto;
Siemens Medical Solutions, Erlangen, Germany) equipped with a 12-channel head
coil, with the same rs-fMRI sequence and parameters for both time points
(<ext-link xlink:href="http://journals.sagepub.com/doi/suppl/10.1177/13524585211030212" ext-link-type="uri">Supplemental Data</ext-link>). A harmonized pre- and post-processing
pipeline was used for all structural (T1 weighted and MPRAGE) and rs-fMRI data
to minimize confounding effects (<ext-link xlink:href="http://journals.sagepub.com/doi/suppl/10.1177/13524585211030212" ext-link-type="uri">Supplemental Data</ext-link>).</p>
      </sec>
      <sec id="section11-13524585211030212">
        <title>ICA and FC matrices</title>
        <p>The cleaned and Montreal Neurological Institute (MNI)-conformed rs-fMRI data were
submitted to temporal concatenation group independent component analysis (gICA)
using MELODIC<sup>
<xref rid="bibr21-13524585211030212" ref-type="bibr">21</xref>
</sup> with a model order of 40 independent components (ICs).<sup><xref rid="bibr22-13524585211030212" ref-type="bibr">22</xref><xref rid="bibr23-13524585211030212" ref-type="bibr"/><xref rid="bibr24-13524585211030212" ref-type="bibr"/>–<xref rid="bibr25-13524585211030212" ref-type="bibr">25</xref></sup> These group-level spatial
components were then used as spatial regressors against each participant’s
rs-fMRI data set to estimate subject-specific component spatial maps and
associated time series (dual regression).<sup><xref rid="bibr22-13524585211030212" ref-type="bibr">22</xref>,<xref rid="bibr24-13524585211030212" ref-type="bibr">24</xref><xref rid="bibr25-13524585211030212" ref-type="bibr"/>–<xref rid="bibr26-13524585211030212" ref-type="bibr">26</xref></sup> After removing 15 ICs
classified as non-CNS based on visual assessment and correlation with the Smith
networks (<ext-link xlink:href="http://journals.sagepub.com/doi/suppl/10.1177/13524585211030212" ext-link-type="uri">Supplementary Figure 1</ext-link>), we extracted a total of 25 ICs for
further analysis (<ext-link xlink:href="http://journals.sagepub.com/doi/suppl/10.1177/13524585211030212" ext-link-type="uri">Supplementary Figure 2</ext-link>). The times series of the noise-ICs was
regressed out of the time series of the kept ICs. We calculated connectivity
matrices using full as well as regularized partial correlations with automatic
estimation of regularization parameters at the individual level.<sup><xref rid="bibr27-13524585211030212" ref-type="bibr">27</xref>,<xref rid="bibr28-13524585211030212" ref-type="bibr">28</xref></sup> Based on
the Euclidean distances of the full temporal correlations, the ICs grouped into
four clusters largely representing (1) and (2) default mode network (DMN) and
frontoparietal areas, (3) auditory network and (4) sensory/motor areas
(<ext-link xlink:href="http://journals.sagepub.com/doi/suppl/10.1177/13524585211030212" ext-link-type="uri">Supplementary Figure 3 and Supplementary Table 1</ext-link>).<sup><xref rid="bibr22-13524585211030212" ref-type="bibr">22</xref><xref rid="bibr23-13524585211030212" ref-type="bibr"/>–<xref rid="bibr24-13524585211030212" ref-type="bibr">24</xref></sup> Since partial
correlations are assumed to represent direct connections between nodes, these
were used in further analyses.</p>
      </sec>
      <sec id="section12-13524585211030212">
        <title>Functional connectome stability</title>
        <p>We computed an index of each MS patient’s longitudinal brain functional
connectome stability using the following procedure: for each patient and for
each time point, we extracted the node–node connectivity measures from the
whole-brain connectivity matrix, creating a vector of length 300 (25 ICs and 300
unique links between them). Then, we calculated the within-subject Spearman
correlation coefficient between the baseline and follow-up connectivity values,
in this way obtaining a measure of whole-brain functional connectome stability.<sup>
<xref rid="bibr16-13524585211030212" ref-type="bibr">16</xref>
</sup> Similarly, and to complement the full-brain index, we computed
within-network connectome stability for each of the four identified
network-clusters. This measure captures any change in the rank of edges between
baseline and follow-up, independent of their direction, thus providing
individual-level global and network-specific measures of longitudinal FC
stability for the MS patients. To further validate the implementation of the
stability index as a global measure of FC changes over time, we correlated
functional connectome stability with the sum of the squared differences in FC
between baseline and follow-up for all edges in each of the MS patients.</p>
      </sec>
      <sec id="section13-13524585211030212">
        <title>Statistical analysis</title>
        <p>For statistical analyses, we used R<sup>
<xref rid="bibr29-13524585211030212" ref-type="bibr">29</xref>
</sup> and MATLAB version 2014a (MathWorks Inc., Natick, MA, USA, 2018).
Group-level changes in performance between baseline and follow-up were tested by
paired sample <italic toggle="yes">t</italic>-tests. We used separate multiple linear
regressions to test for differences in whole-brain FC stability, within-network
FC stability, and FC at the level of single edges between HC and MS patients at
baseline. We performed paired sample <italic toggle="yes">t</italic>-tests to assess edge-
and network-wise changes in FC over time in the MS cohort.</p>
        <p>To test for associations between disease progression and functional
abnormalities, we used multivariate linear models to compare whole-brain, and
within-network, connectome stability between patients with and without evidence
of disease activity (EDA). To test the relation between structural damage and FC
abnormalities, we correlated the connectome stability index with measures of
lesion-filled brain volume and lesion load at baseline, and with brain atrophy
and lesion change at follow-up. For lesion volumes, we used log transformation
to account for the lack of normal distribution in the resulting volumes.</p>
        <p>Finally, we used multiple linear regressions to assess the relationship between
connectome stability and cognition and physical ability at follow-up, and the
change in these tests between baseline and follow-up. We adjusted for sex, age,
estimated mean relative motion and temporal signal-to-noise ratio (tSNR) in all
linear models. Significance was defined as <italic toggle="yes">p</italic> &lt; 0.05
(corrected). We used false discovery rate (FDR; <italic toggle="yes">p</italic> &lt; 0.05)
for the case–control comparisons, the longitudinal analyses and for models
evaluating the clinical relevance of connectome stability. We applied
permutation testing when comparing connectome stability between EDA and NEDA
patients to derive exact <italic toggle="yes">p</italic>-values, since this approach does not
rely on any assumption about the distribution of the stability measure.
Specifically, we obtained an empirical null-distribution of estimates for the
group difference across 1000 permutations randomly permuting the group-label.
The family-wise error was controlled by collecting the maximum test statistic
across the whole-brain and within-network tests for each permutation.<sup>
<xref rid="bibr30-13524585211030212" ref-type="bibr">30</xref>
</sup> The resulting <italic toggle="yes">p</italic>-value was calculated by dividing the
number of permuted beta-values equal or larger than the point estimate by the
total number of permutations.</p>
      </sec>
    </sec>
    <sec sec-type="results" id="section14-13524585211030212">
      <title>Results</title>
      <sec id="section15-13524585211030212">
        <title>Sample characteristics</title>
        <p>The MS sample included 71% (<italic toggle="yes">n</italic> = 54) females. At follow-up, 44%
(<italic toggle="yes">n</italic> = 27) of the patients met criteria for NEDA. The median
EDSS (2.0) score did not change after 5 years. One patient developed
secondary-progressive multiple sclerosis (SPMS) at follow-up. Mean time between
baseline and follow-up was 4.5 years (standard deviation (SD) = 0.4 years, range
= 3.7–5.4 years). Disease-modifying treatment (DMT) was used by 78% and 69% of
the patients at baseline and follow-up, respectively (<xref rid="table1-13524585211030212" ref-type="table">Table 1</xref>). A more detailed description
on the differences between NEDA and EDA patients can be found in <ext-link xlink:href="http://journals.sagepub.com/doi/suppl/10.1177/13524585211030212" ext-link-type="uri">Supplementary Table 2</ext-link>. The NCNG cohort was matched to the MS
sample at baseline by age (mean years = 34.89, SD = 9.17) and sex (74% female).
The Amsterdam HC sample were mostly female (70% female, <italic toggle="yes">n</italic> =
222, mean years = 41.86, SD = 11.44).</p>
        <table-wrap position="float" id="table1-13524585211030212">
          <label>Table 1.</label>
          <caption>
            <p>Demographic and clinical characteristics of the multiple sclerosis
patients.</p>
          </caption>
          <alternatives>
            <graphic xlink:href="10.1177_13524585211030212-table1" position="float"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="char" char="." span="1"/>
                <col align="char" char="." span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left" rowspan="2" colspan="1">(a) Demographic
characteristics</th>
                  <th align="left" rowspan="1" colspan="1">Baseline</th>
                  <th align="left" rowspan="1" colspan="1">Follow-up</th>
                </tr>
                <tr>
                  <th align="left" rowspan="1" colspan="1"><italic toggle="yes">n</italic> = 76</th>
                  <th align="left" rowspan="1" colspan="1"><italic toggle="yes">n</italic> = 62</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td rowspan="1" colspan="1">Female, <italic toggle="yes">n</italic> (%)</td>
                  <td rowspan="1" colspan="1">54 (71)</td>
                  <td rowspan="1" colspan="1">44 (71)</td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1">Age, mean years (SD)</td>
                  <td rowspan="1" colspan="1">35.3 (7.3)</td>
                  <td rowspan="1" colspan="1">40.5 (7.2)</td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1">Disease duration, mean months (SD)</td>
                  <td rowspan="1" colspan="1">71.7 (63)</td>
                  <td rowspan="1" colspan="1">125.1 (60.2)</td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1">Age at first symptom, mean years (SD)</td>
                  <td rowspan="1" colspan="1">29.3 (6.7)</td>
                  <td rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1">Months since diagnosis, mean (SD)</td>
                  <td rowspan="1" colspan="1">14.0 (11.9)</td>
                  <td rowspan="1" colspan="1">66.4 (14.5)</td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1">
<italic toggle="yes">Disease-modifying treatment</italic>
</td>
                  <td rowspan="1" colspan="1"/>
                  <td rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1"> None, <italic toggle="yes">n</italic> (%)</td>
                  <td rowspan="1" colspan="1">17 (22)</td>
                  <td rowspan="1" colspan="1">19 (31)</td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1"> First-line treatment, <italic toggle="yes">n</italic> (%)</td>
                  <td rowspan="1" colspan="1">49 (65)</td>
                  <td rowspan="1" colspan="1">23 (37)</td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1"> Second-line treatment, <italic toggle="yes">n</italic> (%)</td>
                  <td rowspan="1" colspan="1">10 (13)</td>
                  <td rowspan="1" colspan="1">20 (32)</td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1">(b) Clinical evaluation</td>
                  <td rowspan="1" colspan="1"/>
                  <td rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1">
<italic toggle="yes">Multiple sclerosis classification</italic>
</td>
                  <td rowspan="1" colspan="1"/>
                  <td rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1"> RRMS, <italic toggle="yes">n</italic> (%)</td>
                  <td rowspan="1" colspan="1">75 (99)</td>
                  <td rowspan="1" colspan="1">60 (96)</td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1"> PPMS, <italic toggle="yes">n</italic> (%)</td>
                  <td rowspan="1" colspan="1">1 (1)</td>
                  <td rowspan="1" colspan="1">1 (2)</td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1"> SPMS, <italic toggle="yes">n</italic> (%)</td>
                  <td rowspan="1" colspan="1"/>
                  <td rowspan="1" colspan="1">1 (2)</td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1">
<italic toggle="yes">Neurological disability</italic>
</td>
                  <td rowspan="1" colspan="1"/>
                  <td rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1"> EDSS, median (SD, range)</td>
                  <td rowspan="1" colspan="1">2.0 (0.9, 0–6)</td>
                  <td rowspan="1" colspan="1">2.0 (1.3, 0–6)</td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1"> MSSS (SD)</td>
                  <td rowspan="1" colspan="1">4.9 (1.9)</td>
                  <td rowspan="1" colspan="1">2.6 (1.8)</td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1"> Number of total relapses, mean (SD)</td>
                  <td rowspan="1" colspan="1">1.8 (1)</td>
                  <td rowspan="1" colspan="1">2.6 (1.3)</td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1"> FSS, mean (SD)</td>
                  <td rowspan="1" colspan="1">4.2 (1.7)</td>
                  <td rowspan="1" colspan="1">4.1 (1.9)</td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1">(c) NEDA assessment</td>
                  <td rowspan="1" colspan="1"/>
                  <td rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1">NEDA-3, <italic toggle="yes">n</italic> (%)</td>
                  <td rowspan="1" colspan="1"/>
                  <td rowspan="1" colspan="1">27 (44)</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="table-fn1-13524585211030212">
              <p>SD: standard deviation; RRMS: relapsing-remitting multiple sclerosis;
PPMS: primary-progressive multiple sclerosis; SPMS:
secondary-progressive multiple sclerosis; EDSS: Expanded Disability
Status Scale; MSSS: Multiple Sclerosis Severity Scale; FSS: Fatigue
Severity Scale; NEDA: no evidence of disease activity.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>At the group level, MS patients improved on Color Word Interference Test (CWIT)
and California Verbal Learning Test-II (CVLT-II) over time, while no significant
differences between baseline and follow-up were identified for Symbol Digit
Modalities Test (SDMT), T25-FT and 9HPT (<ext-link xlink:href="http://journals.sagepub.com/doi/suppl/10.1177/13524585211030212" ext-link-type="uri">Supplementary Table 3</ext-link>). Only two participants displayed a
significant decrease in physical ability, and none in average cognition
(<ext-link xlink:href="http://journals.sagepub.com/doi/suppl/10.1177/13524585211030212" ext-link-type="uri">Supplementary Figures 4 and 5</ext-link>). We found no associations between
rs-fMRI signal-to-noise ratio and mean relative motion and clinical and
cognitive outcomes (<ext-link xlink:href="http://journals.sagepub.com/doi/suppl/10.1177/13524585211030212" ext-link-type="uri">Supplementary Table 4</ext-link>).</p>
      </sec>
      <sec id="section16-13524585211030212">
        <title>FC abnormalities in MS versus HCs at baseline</title>
        <p><xref rid="fig1-13524585211030212" ref-type="fig">Figure 1</xref> and <ext-link xlink:href="http://journals.sagepub.com/doi/suppl/10.1177/13524585211030212" ext-link-type="uri">Supplementary Figure 6</ext-link> show the results from the edge-wise
comparisons in FC between MS and HCs, revealing edges with both increased as
well as decreased connectivity in patients at baseline. FC in DMN and
frontoparietal networks (networks 1 and 2) was significantly different from HC
(<xref rid="table2-13524585211030212" ref-type="table">Table 2</xref>).
Edge-wise analysis showed that a connection (IC11–IC15) between nodes belonging
to DMN and frontoparietal networks (network 1) was weaker in MS relative to
controls (β = −0.1, <italic toggle="yes">t</italic>(135) = −5.21, <italic toggle="yes">p</italic> =
−0.0002), while another edge (IC6–IC11) within the same networks was stronger in
patients compared to HC (β = 0.07, <italic toggle="yes">t</italic>(135) = 3.54,
<italic toggle="yes">p</italic> = 0.032). An edge (IC10–IC14) between nodes belonging to
DMN and frontoparietal networks (network 2) was higher in MS (β = 0.08,
<italic toggle="yes">t</italic>(135) = 3.74, <italic toggle="yes">p</italic> = 0.002) and another,
(IC7–IC16), between nodes belonging to the auditory networks (network 3) was
weaker in MS patients relative to HC (β = −0.08, <italic toggle="yes">t</italic>(135) =
−3.94, <italic toggle="yes">p</italic> = 0.001). Also, a connection (IC2–IC7) between one
node belonging to auditory networks (network 3) and one node belonging to
sensory and motor networks (network 4) was weaker in MS patients compared to HC
(β = −0.08, <italic toggle="yes">t</italic>(135) = −4.02, <italic toggle="yes">p</italic> = 0.001).</p>
        <fig position="float" id="fig1-13524585211030212">
          <label>Figure 1.</label>
          <caption>
            <p>Edge-wise analyse of functional connectivity (FC) abnormalities.
<italic toggle="yes">T</italic>-values from multivariate linear regressions
assessing differences in FC at the level of single connections between
MS and HCs. Red colours indicate the increased FC in MS, and blue
colours indicate a decrease in FC.</p>
            <p>*<italic toggle="yes">p</italic>-value significant after correction for multiple
testing by false discovery rate (<italic toggle="yes">q</italic> = 0.05).</p>
          </caption>
          <graphic xlink:href="10.1177_13524585211030212-fig1" position="float"/>
        </fig>
        <table-wrap position="float" id="table2-13524585211030212">
          <label>Table 2.</label>
          <caption>
            <p>Within network functional connectivity abnormalities in MS.</p>
          </caption>
          <alternatives>
            <graphic xlink:href="10.1177_13524585211030212-table2" position="float"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="char" char="." span="1"/>
                <col align="char" char="." span="1"/>
                <col align="char" char="." span="1"/>
                <col align="char" char="." span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <th rowspan="1" colspan="1"/>
                  <th align="left" rowspan="1" colspan="1">Beta coefficient</th>
                  <th align="left" rowspan="1" colspan="1"><italic toggle="yes">T</italic>-value</th>
                  <th align="left" rowspan="1" colspan="1">Standard deviation</th>
                  <th align="left" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-value</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td rowspan="1" colspan="1">Full brain</td>
                  <td rowspan="1" colspan="1">−0.001</td>
                  <td rowspan="1" colspan="1">−1.28</td>
                  <td rowspan="1" colspan="1">0.001</td>
                  <td rowspan="1" colspan="1">0.2</td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1">Network 1<break/>DMN and frontoparietal nodes</td>
                  <td rowspan="1" colspan="1">−0.017</td>
                  <td rowspan="1" colspan="1">−3.56</td>
                  <td rowspan="1" colspan="1">0.005</td>
                  <td rowspan="1" colspan="1">0.002<xref rid="table-fn4-13524585211030212" ref-type="table-fn">*</xref></td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1">Network 2<break/>DMN and frontoparietal nodes</td>
                  <td rowspan="1" colspan="1">−0.011</td>
                  <td rowspan="1" colspan="1">−3.14</td>
                  <td rowspan="1" colspan="1">0.003</td>
                  <td rowspan="1" colspan="1">0.004<xref rid="table-fn4-13524585211030212" ref-type="table-fn">*</xref></td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1">Network 3<break/>Auditory nodes</td>
                  <td rowspan="1" colspan="1">−0.009</td>
                  <td rowspan="1" colspan="1">−1.59</td>
                  <td rowspan="1" colspan="1">0.006</td>
                  <td rowspan="1" colspan="1">0.15</td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1">Network 4<break/>Sensory and motor nodes</td>
                  <td rowspan="1" colspan="1">0.002</td>
                  <td rowspan="1" colspan="1">0.41</td>
                  <td rowspan="1" colspan="1">0.005</td>
                  <td rowspan="1" colspan="1">0.68</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="table-fn2-13524585211030212">
              <p>MS: multiple sclerosis; DMN: default mode network.</p>
            </fn>
            <fn id="table-fn3-13524585211030212">
              <p>Results of multivariate linear regression models corrected for sex,
age, mean relative motion and signal-to-noise ratio.
<italic toggle="yes">p</italic>-values corrected for multiple testing by
false discovery rate.</p>
            </fn>
            <fn id="table-fn4-13524585211030212">
              <label>*</label>
              <p><italic toggle="yes">p</italic>-value significant after correction for multiple
testing by false discovery rate.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>At the group level, paired sample <italic toggle="yes">t</italic>-tests revealed no
significant edge-wise longitudinal FC changes in the MS cohort (<ext-link xlink:href="http://journals.sagepub.com/doi/suppl/10.1177/13524585211030212" ext-link-type="uri">Supplementary Figures 7 and 8 and Supplementary Table 5</ext-link>).
Additional analyses to evaluate the robustness of our approach, including
careful lesion masking during the estimation of the node time series, excluding
the two subjects with progressive forms of MS, or expanding the IC model order
to 50, did not change the main effects or interpretation of the results
(<ext-link xlink:href="http://journals.sagepub.com/doi/suppl/10.1177/13524585211030212" ext-link-type="uri">Supplementary Table 8 and Supplementary Figure 9</ext-link>).</p>
      </sec>
      <sec id="section17-13524585211030212">
        <title>Longitudinal functional connectome stability</title>
        <p>The stability of the brain functional connectome in the whole MS cohort, and in
the EDA and NEDA subgroups is depicted in <xref rid="fig2-13524585211030212" ref-type="fig">Figure 2</xref>, enabling visualization of FC
changes due to disease progression. Functional connectome stability of the nodes
clustering with DMN and frontoparietal networks (network 2) was nominally lower
in EDA patients compared to NEDA patients (β = 0.14, <italic toggle="yes">t</italic>(34) =
2.26, <italic toggle="yes">p</italic> = 0.03), but this effect did not survive correction for
multiple testing (<ext-link xlink:href="http://journals.sagepub.com/doi/suppl/10.1177/13524585211030212" ext-link-type="uri">Supplementary Table 6</ext-link>). We found no association between
functional connectome stability and measures of lesion-filled (<ext-link xlink:href="http://journals.sagepub.com/doi/suppl/10.1177/13524585211030212" ext-link-type="uri">Supplementary Table 7</ext-link>) brain volume and lesion load at baseline
(<ext-link xlink:href="http://journals.sagepub.com/doi/suppl/10.1177/13524585211030212" ext-link-type="uri">Supplementary Figure 10</ext-link>), nor with brain atrophy or lesion
volume changes (<ext-link xlink:href="http://journals.sagepub.com/doi/suppl/10.1177/13524585211030212" ext-link-type="uri">Supplementary Figure 11</ext-link>).</p>
        <fig position="float" id="fig2-13524585211030212">
          <label>Figure 2.</label>
          <caption>
            <p>Stability of the brain functional connectome between baseline and
follow-up for the MS sample as a whole, and for the subgroups of EDA and
NEDA, respectively, for the global estimate and all resulting
networks.</p>
          </caption>
          <graphic xlink:href="10.1177_13524585211030212-fig2" position="float"/>
        </fig>
        <p>Functional connectome stability was highly correlated with the sum of the squared
differences in FC between baseline and follow-up (ρ = −0.59, <italic toggle="yes">p</italic>
&lt; 0.0001).</p>
      </sec>
      <sec id="section18-13524585211030212">
        <title>Clinical relevance of FC changes</title>
        <p>Finally, we tested for associations between changes in FC and cognitive
performance and physical ability using general linear models with average
cognition and physical ability at follow-up as dependent variables, covarying
for age, sex, signal-to-noise ratio and mean relative motion. Younger age (β =
−0.03, <italic toggle="yes">t</italic>(34) = −2.08, <italic toggle="yes">p</italic> = 0.045) was
associated with better cognitive performance at follow-up (<xref rid="fig3-13524585211030212" ref-type="fig">Figure 3(a)</xref>), but did not survive
correction for multiple testing (adjusted <italic toggle="yes">p</italic> = 0.089). No
significant associations between longitudinal changes in cognitive performance
and functional connectome stability, age, sex, signal-to-noise ratio nor mean
relative motion were found. (<xref rid="fig3-13524585211030212" ref-type="fig">Figure 3(b)</xref>).</p>
        <fig position="float" id="fig3-13524585211030212">
          <label>Figure 3.</label>
          <caption>
            <p>Effect of functional connectome stability on cognitive performance and
physical ability. (a) Effect of FC stability on average cognition at
follow-up, β = 1.98, <italic toggle="yes">t</italic>(34) = 1.20, <italic toggle="yes">p</italic> =
0.54. (b) Effect of FC stability on average change in cognition, β =
1.00, <italic toggle="yes">t</italic>(33) = 0.64, <italic toggle="yes">p</italic> = 0.69. (c)
Effect of FC stability on physical ability at follow-up, β = 4.56,
<italic toggle="yes">t</italic>(34) = 2.00, <italic toggle="yes">p</italic> = 0.21. (d) Effect
of FC stability on average change in physical ability, β = 0.89,
<italic toggle="yes">t</italic>(33) = 0.33, <italic toggle="yes">p</italic> = 0.75.</p>
            <p><italic toggle="yes">p</italic>-values corrected for multiple testing by false
discovery rate.</p>
          </caption>
          <graphic xlink:href="10.1177_13524585211030212-fig3" position="float"/>
        </fig>
        <p>For physical ability, lower functional connectome stability (β = 4.56,
<italic toggle="yes">t</italic>(34) = 2.00, <italic toggle="yes">p</italic> = 0.05), higher age at
follow-up (β = −0.05, <italic toggle="yes">t</italic>(34) = −2.45, <italic toggle="yes">p</italic> = 0.02)
and sex, with women scoring better than men, (β = 0.70, <italic toggle="yes">t</italic>(34) =
2.46, <italic toggle="yes">p</italic> = 0.02) were nominally associated with decreased
physical ability at follow-up (<xref rid="fig3-13524585211030212" ref-type="fig">Figure 3(c)</xref>), but none of these effects survived correction for
multiple testing. Neither stability of the brain functional connectome, age,
sex, signal-to-noise ratio nor mean relative motion were associated with changes
in physical performance over time (<xref rid="fig3-13524585211030212" ref-type="fig">Figure 3(d)</xref>).</p>
      </sec>
    </sec>
    <sec sec-type="discussion" id="section19-13524585211030212">
      <title>Discussion</title>
      <p>In this 5-year longitudinal prospective MS study, we investigated the clinical
relevance of an fMRI-derived individual-level longitudinal index of global
functional connectome stability. In addition, we performed a cross-sectional
case–control comparison with a matched HC sample, assessing aberrant FC in MS
patients at baseline.</p>
      <p>The case–control comparison replicated previous reports of FC differences in MS
compared to HC,<sup><xref rid="bibr4-13524585211030212" ref-type="bibr">4</xref>,<xref rid="bibr11-13524585211030212" ref-type="bibr">11</xref>,<xref rid="bibr14-13524585211030212" ref-type="bibr">14</xref></sup> supporting our first hypothesis that FC aberrations are present
already in the first decade of acquiring MS. Schoonheim et al.<sup>
<xref rid="bibr31-13524585211030212" ref-type="bibr">31</xref>
</sup> (2010) proposed a model for functional reorganization of the brain in
relation to structural damage and clinical impairment in MS, in which, at least in
the first decade of the disease, a compensatory increase in FC buffers clinical and
cognitive consequences of MS-related structural damage. Accumulating evidence has
since been established, describing a more complex pattern of FC aberrations in
MS.<sup><xref rid="bibr4-13524585211030212" ref-type="bibr">4</xref>,<xref rid="bibr11-13524585211030212" ref-type="bibr">11</xref>,<xref rid="bibr13-13524585211030212" ref-type="bibr">13</xref></sup></p>
      <p>Investigating the longitudinal stability of the brain functional connectome at the
individual level allowed us to study the complex and heterogeneous dynamics of FC
aberrations in MS. The concept of connectome stability enabled us to test the
hypothesis presented by Schoonheim et al.,<sup>
<xref rid="bibr31-13524585211030212" ref-type="bibr">31</xref>
</sup> accounting for the whole set of FC alterations characterizing MS. Our
analysis revealed that connectome stability of nodes clustering with the DMN and
frontoparietal networks (network 2) were nominally lower in EDA patients compared to
NEDA patients; however, the result did not remain significant after correcting for
multiple testing. Furthermore, neither lesion-filled brain volume nor lesion load
was associated with connectome stability in both cross-sectional and longitudinal
models (<ext-link xlink:href="http://journals.sagepub.com/doi/suppl/10.1177/13524585211030212" ext-link-type="uri">Supplementary Figures 10 and 11</ext-link>). Importantly, we found no
significant associations between connectome stability and progression of cognitive
and physical impairment. A possible explanation for the lack of clinical
associations might be that our subjects were remarkably stable at follow-up
(<ext-link xlink:href="http://journals.sagepub.com/doi/suppl/10.1177/13524585211030212" ext-link-type="uri">Supplementary Figures 4 and 5</ext-link>). At follow-up, 44% of the MS subjects
were classified with NEDA (<ext-link xlink:href="http://journals.sagepub.com/doi/suppl/10.1177/13524585211030212" ext-link-type="uri">Supplementary Table 2</ext-link>)</p>
      <p>Similar implementations of connectome stability have previously been used to study
mental health in youth,<sup>
<xref rid="bibr32-13524585211030212" ref-type="bibr">32</xref>
</sup> severe mental disorders<sup>
<xref rid="bibr16-13524585211030212" ref-type="bibr">16</xref>
</sup> and cognitive ageing.<sup>
<xref rid="bibr33-13524585211030212" ref-type="bibr">33</xref>
</sup> In order to supplement the rank-based estimate, we correlated the index of
connectome stability with an alternative operationalization based on the sum of the
squared differences between time points, which revealed highly corresponding
estimates. In general, our results are in line with the few previous findings
showing FC abnormalities in the first decade of the disease and, in accordance with
Rocca et al., we found that FC alterations did not correlate with lesion
load.<sup><xref rid="bibr4-13524585211030212" ref-type="bibr">4</xref>,<xref rid="bibr14-13524585211030212" ref-type="bibr">14</xref></sup></p>
      <p>Limitations of this study include lack of MRI follow-up for HC, preventing this study
to draw conclusions on whether the longitudinal changes are specific to MS. Since HC
only performed cognitive tests at baseline, we used these results to create the
<italic toggle="yes">Z</italic>-scores for MS patients at follow-up.
<italic toggle="yes">Z</italic>-scores for physical ability were based on analyses of performance
of MS patients only. To reduce the practice effects on the cognitive tests, the MS
patients completed alternative subtests in the cognitive test battery to reduce the
task familiarity effects.<sup>
<xref rid="bibr34-13524585211030212" ref-type="bibr">34</xref>
</sup> The sample size of our MS cohort is comparable with that of previous studies
investigating FC longitudinally, but larger samples may be needed to identify subtle
associations between brain network dynamics and clinical characteristics.<sup>
<xref rid="bibr14-13524585211030212" ref-type="bibr">14</xref>
</sup></p>
    </sec>
    <sec sec-type="conclusions" id="section20-13524585211030212">
      <title>Conclusion</title>
      <p>In this longitudinal study, we found that our MS cohort was clinically stable with
preserved cognitive abilities. We revealed FC abnormalities at baseline supporting
earlier studies showing FC aberrations already in the first decade of MS. We found
that connectome-wise FC stability cannot be predicted by the level of lesion load or
brain volume, both in a cross-sectional and longitudinal setting. Future large-scale
longitudinal fMRI studies are needed to confirm the sensitivity and clinical
relevance of the fMRI-derived connectome stability index, and to map associations
with trajectories of physical and cognitive changes in MS, preferably also with
longitudinal HC fMRI data.</p>
    </sec>
    <sec sec-type="supplementary-material" id="section21-13524585211030212" specific-use="figshare">
      <title>Supplemental Material</title>
      <supplementary-material id="suppl1-13524585211030212" position="float" content-type="local-data">
        <caption>
          <title>sj-docx-1-msj-10.1177_13524585211030212 – Supplemental material for
Functional connectivity in multiple sclerosis modelled as connectome
stability: A 5-year follow-up study</title>
        </caption>
        <media xlink:href="sj-docx-1-msj-10.1177_13524585211030212.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
        <p>Supplemental material, sj-docx-1-msj-10.1177_13524585211030212 for Functional
connectivity in multiple sclerosis modelled as connectome stability: A 5-year
follow-up study by Einar August Høgestøl, Samuele Ghezzo, Gro Owren Nygaard,
Thomas Espeseth, Piotr Sowa, Mona K Beyer, Hanne Flinstad Harbo, Lars T Westlye,
Hanneke E Hulst and Dag Alnæs in Multiple Sclerosis Journal</p>
      </supplementary-material>
      <supplementary-material id="suppl2-13524585211030212" position="float" content-type="local-data">
        <caption>
          <title>sj-docx-2-msj-10.1177_13524585211030212 – Supplemental material for
Functional connectivity in multiple sclerosis modelled as connectome
stability: A 5-year follow-up study</title>
        </caption>
        <media xlink:href="sj-docx-2-msj-10.1177_13524585211030212.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
        <p>Supplemental material, sj-docx-2-msj-10.1177_13524585211030212 for Functional
connectivity in multiple sclerosis modelled as connectome stability: A 5-year
follow-up study by Einar August Høgestøl, Samuele Ghezzo, Gro Owren Nygaard,
Thomas Espeseth, Piotr Sowa, Mona K Beyer, Hanne Flinstad Harbo, Lars T Westlye,
Hanneke E Hulst and Dag Alnæs in Multiple Sclerosis Journal</p>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <p>The authors thank all patients participating in this study. The authors acknowledge
the collaboration with members of the Multiple Sclerosis Research Group and NORMENT
at the University of Oslo and Oslo University Hospital, especially Elisabeth G.
Celius for her guidance during the investigations of the MS patients and Tobias
Kaufmann for valuable help and input on the statistical approach. The authors also
thank the research assistants Kristin Liltved Grønsberg, May-Britt Gjengstø Utheim,
Julia Timofeeva, Hedda Maurud, Siren Tønnessen and Petter Espeseth Emhjellen who all
contributed to the cognitive testing of the patients.</p>
    </ack>
    <fn-group>
      <fn fn-type="COI-statement">
        <p><bold>Declaration of Conflicting Interests:</bold> The author(s) declared the following potential conflicts of interest with respect
to the research, authorship, and/or publication of this article: S.G., G.O.N.,
T.E., L.T.W. and D.A. report no disclosures. E.A.H. has received honoraria for
lecturing from Biogen, Merck and Sanofi-Genzyme, and unrestricted research
support from Merck and Sanofi-Genzyme. P.S. has received honoraria for lecturing
and travel support from Merck. M.K.B. has received honoraria for lecturing from
Novartis and Biogen Idec. H.F.H. has received travel support, honoraria for
advice or lecturing from Biogen Idec, Sanofi-Genzyme, Merck, Novartis, Roche and
Teva, and an unrestricted research grant from Novartis. H.E.H. received
honoraria for speaking at scientific meetings, serving at scientific advisory
boards and consulting activities from Biogen, Celgene, Genzyme, Merck and Roche.
She has received research support from the Dutch MS Research Foundation and
serves on the editorial board of Multiple Sclerosis Journal (MSJ).</p>
      </fn>
      <fn fn-type="financial-disclosure">
        <p><bold>Funding:</bold> The author(s) disclosed receipt of the following financial support for the
research, authorship, and/or publication of this article: This work was
supported by grants from the South Eastern Health Authorities of Norway (grant
nos 2011059/ES563338/Biotek 2021, 2019107 and 2020086), the European Research
Council under the European Union’s Horizon 2020 Research and Innovation
Programme (ERC StG, grant no. 802998) and by the European Union under the
Horizon 2020 Programme (grant no. 733161).</p>
      </fn>
      <fn fn-type="other">
        <p><bold>Data Availability Statement:</bold> Summary data as published in this article will be available, but other data are
not publicly available because of patient privacy restrictions decided by the
Regional Ethical Committee. We may apply for permission to share data with new
collaborators, still adhering to patient privacy requirements of the ‘Law of
Health Research’. All code needed to replicate our described analyses is
available upon request from the corresponding author.</p>
      </fn>
      <fn fn-type="other">
        <p><bold>ORCID iDs:</bold> Einar August Høgestøl <inline-graphic xlink:href="10.1177_13524585211030212-img1.jpg"/>
<ext-link xlink:href="https://orcid.org/0000-0001-8446-2111" ext-link-type="uri">https://orcid.org/0000-0001-8446-2111</ext-link></p>
        <p>Hanneke E Hulst <inline-graphic xlink:href="10.1177_13524585211030212-img1.jpg"/>
<ext-link xlink:href="https://orcid.org/0000-0002-5039-1359" ext-link-type="uri">https://orcid.org/0000-0002-5039-1359</ext-link></p>
      </fn>
      <fn fn-type="supplementary-material">
        <p><bold>Supplemental Material:</bold> Supplemental material for this article is available online.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="bibr1-13524585211030212">
        <label>1.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Barkhof</surname><given-names>F.</given-names></name>
</person-group>
<article-title>The clinico-radiological paradox in multiple sclerosis
revisited</article-title>. <source>Curr Opin Neurol</source>
<year>2002</year>; <volume>15</volume>(<issue>3</issue>):
<fpage>239</fpage>–<lpage>245</lpage>.<pub-id pub-id-type="pmid">12045719</pub-id></mixed-citation>
      </ref>
      <ref id="bibr2-13524585211030212">
        <label>2.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chard</surname><given-names>D</given-names></name>
<name><surname>Trip</surname><given-names>SA.</given-names></name>
</person-group>
<article-title>Resolving the clinico-radiological paradox in multiple
sclerosis</article-title>. <source>F1000Res</source>
<year>2017</year>; <volume>6</volume>: <year>1828</year>.</mixed-citation>
      </ref>
      <ref id="bibr3-13524585211030212">
        <label>3.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Peer</surname><given-names>M</given-names></name>
<name><surname>Nitzan</surname><given-names>M</given-names></name>
<name><surname>Bick</surname><given-names>AS</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>Evidence for functional
networks within the human brain’s white matter</article-title>. <source>J
Neurosci</source>
<year>2017</year>; <volume>37</volume>(<issue>27</issue>):
<fpage>6394</fpage>–<lpage>6407</lpage>.<pub-id pub-id-type="pmid">28546311</pub-id></mixed-citation>
      </ref>
      <ref id="bibr4-13524585211030212">
        <label>4.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chard</surname><given-names>DT</given-names></name>
<name><surname>Alahmadi</surname><given-names>AAS</given-names></name>
<name><surname>Audoin</surname><given-names>B</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>Mind the gap: From neurons
to networks to outcomes in multiple sclerosis</article-title>. <source>Nat
Rev Neurol</source>
<year>2021</year>; <volume>17</volume>:
<fpage>173</fpage>–<lpage>184</lpage>.<pub-id pub-id-type="pmid">33437067</pub-id></mixed-citation>
      </ref>
      <ref id="bibr5-13524585211030212">
        <label>5.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Smith</surname><given-names>SM</given-names></name>
<name><surname>Fox</surname><given-names>PT</given-names></name>
<name><surname>Miller</surname><given-names>KL</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>Correspondence of the
brain’s functional architecture during activation and rest</article-title>.
<source>Proc Natl Acad Sci U S A</source>
<year>2009</year>; <volume>106</volume>(<issue>31</issue>):
<fpage>13040</fpage>–<lpage>13045</lpage>.<pub-id pub-id-type="pmid">19620724</pub-id></mixed-citation>
      </ref>
      <ref id="bibr6-13524585211030212">
        <label>6.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Basile</surname><given-names>B</given-names></name>
<name><surname>Castelli</surname><given-names>M</given-names></name>
<name><surname>Monteleone</surname><given-names>F</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>Functional connectivity
changes within specific networks parallel the clinical evolution of multiple
sclerosis</article-title>. <source>Mult Scler</source>
<year>2014</year>; <volume>20</volume>(<issue>8</issue>):
<fpage>1050</fpage>–<lpage>1057</lpage>.<pub-id pub-id-type="pmid">24326671</pub-id></mixed-citation>
      </ref>
      <ref id="bibr7-13524585211030212">
        <label>7.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rocca</surname><given-names>MA</given-names></name>
<name><surname>Valsasina</surname><given-names>P</given-names></name>
<name><surname>Martinelli</surname><given-names>V</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>Large-scale neuronal network
dysfunction in relapsing-remitting multiple sclerosis</article-title>.
<source>Neurology</source>
<year>2012</year>; <volume>79</volume>(<issue>14</issue>):
<fpage>1449</fpage>–<lpage>1457</lpage>.<pub-id pub-id-type="pmid">22955126</pub-id></mixed-citation>
      </ref>
      <ref id="bibr8-13524585211030212">
        <label>8.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rocca</surname><given-names>MA</given-names></name>
<name><surname>Valsasina</surname><given-names>P</given-names></name>
<name><surname>Leavitt</surname><given-names>VM</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>Functional network
connectivity abnormalities in multiple sclerosis: Correlations with
disability and cognitive impairment</article-title>. <source>Mult
Scler</source>
<year>2018</year>; <volume>24</volume>(<issue>4</issue>):
<fpage>459</fpage>–<lpage>471</lpage>.<pub-id pub-id-type="pmid">28294693</pub-id></mixed-citation>
      </ref>
      <ref id="bibr9-13524585211030212">
        <label>9.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hawellek</surname><given-names>DJ</given-names></name>
<name><surname>Hipp</surname><given-names>JF</given-names></name>
<name><surname>Lewis</surname><given-names>CM</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>Increased functional
connectivity indicates the severity of cognitive impairment in multiple
sclerosis</article-title>. <source>Proc Natl Acad Sci U S A</source>
<year>2011</year>; <volume>108</volume>(<issue>47</issue>):
<fpage>19066</fpage>–<lpage>19071</lpage>.<pub-id pub-id-type="pmid">22065778</pub-id></mixed-citation>
      </ref>
      <ref id="bibr10-13524585211030212">
        <label>10.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rocca</surname><given-names>MA</given-names></name>
<name><surname>Valsasina</surname><given-names>P</given-names></name>
<name><surname>Absinta</surname><given-names>M</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>Default-mode network
dysfunction and cognitive impairment in progressive MS</article-title>.
<source>Neurology</source>
<year>2010</year>; <volume>74</volume>(<issue>16</issue>):
<fpage>1252</fpage>–<lpage>1259</lpage>.<pub-id pub-id-type="pmid">20404306</pub-id></mixed-citation>
      </ref>
      <ref id="bibr11-13524585211030212">
        <label>11.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Tahedl</surname><given-names>M</given-names></name>
<name><surname>Levine</surname><given-names>SM</given-names></name>
<name><surname>Greenlee</surname><given-names>MW</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>Functional connectivity in
multiple sclerosis: Recent findings and future directions</article-title>.
<source>Front Neurol</source>
<year>2018</year>; <volume>9</volume>: <fpage>828</fpage>.<pub-id pub-id-type="pmid">30364281</pub-id></mixed-citation>
      </ref>
      <ref id="bibr12-13524585211030212">
        <label>12.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Faivre</surname><given-names>A</given-names></name>
<name><surname>Rico</surname><given-names>A</given-names></name>
<name><surname>Zaaraoui</surname><given-names>W</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>Assessing brain connectivity
at rest is clinically relevant in early multiple sclerosis</article-title>.
<source>Mult Scler</source>
<year>2012</year>; <volume>18</volume>(<issue>9</issue>):
<fpage>1251</fpage>–<lpage>1258</lpage>.<pub-id pub-id-type="pmid">22307385</pub-id></mixed-citation>
      </ref>
      <ref id="bibr13-13524585211030212">
        <label>13.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Schoonheim</surname><given-names>MM</given-names></name>
<name><surname>Meijer</surname><given-names>KA</given-names></name>
<name><surname>Geurts</surname><given-names>JJ.</given-names></name>
</person-group>
<article-title>Network collapse and cognitive impairment in multiple
sclerosis</article-title>. <source>Front Neurol</source>
<year>2015</year>; <volume>6</volume>: <fpage>82</fpage>.<pub-id pub-id-type="pmid">25926813</pub-id></mixed-citation>
      </ref>
      <ref id="bibr14-13524585211030212">
        <label>14.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rocca</surname><given-names>MA</given-names></name>
<name><surname>Hidalgo de La Cruz</surname><given-names>M</given-names></name>
<name><surname>Valsasina</surname><given-names>P</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>Two-year dynamic functional
network connectivity in clinically isolated syndrome</article-title>.
<source>Multiple Sclerosis</source>
<year>2020</year>; <volume>26</volume>:
<fpage>645</fpage>–<lpage>658</lpage>.<pub-id pub-id-type="pmid">30887875</pub-id></mixed-citation>
      </ref>
      <ref id="bibr15-13524585211030212">
        <label>15.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Nasios</surname><given-names>G</given-names></name>
<name><surname>Bakirtzis</surname><given-names>C</given-names></name>
<name><surname>Messinis</surname><given-names>L.</given-names></name>
</person-group>
<article-title>Cognitive impairment and brain reorganization in MS: Underlying
mechanisms and the role of neurorehabilitation</article-title>.
<source>Front Neurol</source>
<year>2020</year>; <volume>11</volume>: <fpage>147</fpage>.<pub-id pub-id-type="pmid">32210905</pub-id></mixed-citation>
      </ref>
      <ref id="bibr16-13524585211030212">
        <label>16.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kaufmann</surname><given-names>T</given-names></name>
<name><surname>Alnaes</surname><given-names>D</given-names></name>
<name><surname>Brandt</surname><given-names>CL</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>Stability of the brain
functional connectome fingerprint in individuals with
schizophrenia</article-title>. <source>JAMA Psychiatry</source>
<year>2018</year>; <volume>75</volume>(<issue>7</issue>):
<fpage>749</fpage>–<lpage>751</lpage>.<pub-id pub-id-type="pmid">29799905</pub-id></mixed-citation>
      </ref>
      <ref id="bibr17-13524585211030212">
        <label>17.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Høgestøl</surname><given-names>EA</given-names></name>
<name><surname>Kaufmann</surname><given-names>T</given-names></name>
<name><surname>Nygaard</surname><given-names>GO</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>Cross-sectional and
longitudinal MRI brain scans reveal accelerated brain aging in multiple
sclerosis</article-title>. <source>Front Neurol</source>
<year>2019</year>; <volume>10</volume>: <fpage>450</fpage>.<pub-id pub-id-type="pmid">31114541</pub-id></mixed-citation>
      </ref>
      <ref id="bibr18-13524585211030212">
        <label>18.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Polman</surname><given-names>CH</given-names></name>
<name><surname>Reingold</surname><given-names>SC</given-names></name>
<name><surname>Banwell</surname><given-names>B</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>Diagnostic criteria for
multiple sclerosis: 2010 revisions to the McDonald criteria</article-title>.
<source>Ann Neurol</source>
<year>2011</year>; <volume>69</volume>(<issue>2</issue>):
<fpage>292</fpage>–<lpage>302</lpage>.<pub-id pub-id-type="pmid">21387374</pub-id></mixed-citation>
      </ref>
      <ref id="bibr19-13524585211030212">
        <label>19.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Espeseth</surname><given-names>T</given-names></name>
<name><surname>Christoforou</surname><given-names>A</given-names></name>
<name><surname>Lundervold</surname><given-names>AJ</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>Imaging and cognitive
genetics: The Norwegian cognitive neurogenetics sample</article-title>.
<source>Twin Res Hum Genet</source>
<year>2012</year>; <volume>15</volume>(<issue>3</issue>):
<fpage>442</fpage>–<lpage>452</lpage>.<pub-id pub-id-type="pmid">22856377</pub-id></mixed-citation>
      </ref>
      <ref id="bibr20-13524585211030212">
        <label>20.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Langdon</surname><given-names>DW</given-names></name>
<name><surname>Amato</surname><given-names>MP</given-names></name>
<name><surname>Boringa</surname><given-names>J</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>Recommendations for a brief
international cognitive assessment for multiple sclerosis
(BICAMS)</article-title>. <source>Mult Scler</source>
<year>2012</year>; <volume>18</volume>(<issue>6</issue>):
<fpage>891</fpage>–<lpage>898</lpage>.<pub-id pub-id-type="pmid">22190573</pub-id></mixed-citation>
      </ref>
      <ref id="bibr21-13524585211030212">
        <label>21.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Beckmann</surname><given-names>CF</given-names></name>
<name><surname>DeLuca</surname><given-names>M</given-names></name>
<name><surname>Devlin</surname><given-names>JT</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>Investigations into
resting-state connectivity using independent component
analysis</article-title>. <source>Philos Trans R Soc Lond B Biol
Sci</source>
<year>2005</year>; <volume>360</volume>(<issue>1457</issue>):
<fpage>1001</fpage>–<lpage>1013</lpage>.<pub-id pub-id-type="pmid">16087444</pub-id></mixed-citation>
      </ref>
      <ref id="bibr22-13524585211030212">
        <label>22.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Skatun</surname><given-names>KC</given-names></name>
<name><surname>Kaufmann</surname><given-names>T</given-names></name>
<name><surname>Brandt</surname><given-names>CL</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>Thalamo-cortical functional
connectivity in schizophrenia and bipolar disorder</article-title>.
<source>Brain Imaging Behav</source>
<year>2018</year>; <volume>12</volume>(<issue>3</issue>):
<fpage>640</fpage>–<lpage>652</lpage>.<pub-id pub-id-type="pmid">28444556</pub-id></mixed-citation>
      </ref>
      <ref id="bibr23-13524585211030212">
        <label>23.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Alnaes</surname><given-names>D</given-names></name>
<name><surname>Kaufmann</surname><given-names>T</given-names></name>
<name><surname>Richard</surname><given-names>G</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>Attentional load modulates
large-scale functional brain connectivity beyond the core attention
networks</article-title>. <source>Neuroimage</source>
<year>2015</year>; <volume>109</volume>:
<fpage>260</fpage>–<lpage>272</lpage>.<pub-id pub-id-type="pmid">25595500</pub-id></mixed-citation>
      </ref>
      <ref id="bibr24-13524585211030212">
        <label>24.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Dorum</surname><given-names>ES</given-names></name>
<name><surname>Kaufmann</surname><given-names>T</given-names></name>
<name><surname>Alnæs</surname><given-names>D</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>Functional brain network
modeling in sub-acute stroke patients and healthy controls during rest and
continuous attentive tracking</article-title>. <source>Heliyon</source>
<year>2020</year>; <volume>6</volume>(<issue>9</issue>):
<fpage>e04854</fpage>.<pub-id pub-id-type="pmid">32995596</pub-id></mixed-citation>
      </ref>
      <ref id="bibr25-13524585211030212">
        <label>25.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mowinckel</surname><given-names>AM</given-names></name>
<name><surname>Alnæs</surname><given-names>D</given-names></name>
<name><surname>Pedersen</surname><given-names>ML</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>Increased default-mode
variability is related to reduced task-performance and is evident in adults
with ADHD</article-title>. <source>Neuroimage Clin</source>
<year>2017</year>; <volume>16</volume>:
<fpage>369</fpage>–<lpage>382</lpage>.<pub-id pub-id-type="pmid">28861338</pub-id></mixed-citation>
      </ref>
      <ref id="bibr26-13524585211030212">
        <label>26.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Nickerson</surname><given-names>LD</given-names></name>
<name><surname>Smith</surname><given-names>SM</given-names></name>
<name><surname>Ongur</surname><given-names>D</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>Using dual regression to
investigate network shape and amplitude in functional connectivity
analyses</article-title>. <source>Front Neurosci</source>
<year>2017</year>; <volume>11</volume>: <fpage>115</fpage>.<pub-id pub-id-type="pmid">28348512</pub-id></mixed-citation>
      </ref>
      <ref id="bibr27-13524585211030212">
        <label>27.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ledoit</surname><given-names>O</given-names></name>
<name><surname>Wolf</surname><given-names>M.</given-names></name>
</person-group>
<article-title>Improved estimation of the covariance matrix of stock returns
with an application to portfolio selection</article-title>. <source>J
Empirical Finance</source>
<year>2003</year>; <volume>10</volume>(<issue>5</issue>):
<fpage>603</fpage>–<lpage>621</lpage>.</mixed-citation>
      </ref>
      <ref id="bibr28-13524585211030212">
        <label>28.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Brier</surname><given-names>MR</given-names></name>
<name><surname>Mitra</surname><given-names>A</given-names></name>
<name><surname>McCarthy</surname><given-names>JE</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>Partial covariance based
functional connectivity computation using Ledoit-Wolf covariance
regularization</article-title>. <source>Neuroimage</source>
<year>2015</year>; <volume>121</volume>:
<fpage>29</fpage>–<lpage>38</lpage>.<pub-id pub-id-type="pmid">26208872</pub-id></mixed-citation>
      </ref>
      <ref id="bibr29-13524585211030212">
        <label>29.</label>
        <mixed-citation publication-type="book">
<collab>R Core Team</collab>. <source>R: A Language and Environment for
Statistical Computing</source>. <publisher-loc>Vienna,
Austria</publisher-loc>: <publisher-name>R Foundation for Statistical
Computing</publisher-name>, <year>2017</year>.</mixed-citation>
      </ref>
      <ref id="bibr30-13524585211030212">
        <label>30.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Singh</surname><given-names>KD</given-names></name>
<name><surname>Barnes</surname><given-names>GR</given-names></name>
<name><surname>Hillebrand</surname><given-names>A.</given-names></name>
</person-group>
<article-title>Group imaging of task-related changes in cortical synchronisation
using nonparametric permutation testing</article-title>.
<source>Neuroimage</source>
<year>2003</year>; <volume>19</volume>(<issue>4</issue>):
<fpage>1589</fpage>–<lpage>1601</lpage>.<pub-id pub-id-type="pmid">12948714</pub-id></mixed-citation>
      </ref>
      <ref id="bibr31-13524585211030212">
        <label>31.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Schoonheim</surname><given-names>MM</given-names></name>
<name><surname>Geurts</surname><given-names>JJ</given-names></name>
<name><surname>Barkhof</surname><given-names>F.</given-names></name>
</person-group>
<article-title>The limits of functional reorganization in multiple
sclerosis</article-title>. <source>Neurology</source>
<year>2010</year>; <volume>74</volume>(<issue>16</issue>):
<fpage>1246</fpage>–<lpage>1247</lpage>.<pub-id pub-id-type="pmid">20404304</pub-id></mixed-citation>
      </ref>
      <ref id="bibr32-13524585211030212">
        <label>32.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kaufmann</surname><given-names>T</given-names></name>
<name><surname>Alnæs</surname><given-names>D</given-names></name>
<name><surname>Doan</surname><given-names>NT</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>Delayed stabilization and
individualization in connectome development are related to psychiatric
disorders</article-title>. <source>Nat Neurosci</source>
<year>2017</year>; <volume>20</volume>:
<fpage>513</fpage>–<lpage>515</lpage>.<pub-id pub-id-type="pmid">28218917</pub-id></mixed-citation>
      </ref>
      <ref id="bibr33-13524585211030212">
        <label>33.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ousdal</surname><given-names>OT</given-names></name>
<name><surname>Kaufmann</surname><given-names>T</given-names></name>
<name><surname>Kolskår</surname><given-names>K</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>Longitudinal stability of
the brain functional connectome is associated with episodic memory
performance in aging</article-title>. <source>Human Brain Mapping</source>
<year>2020</year>; <volume>41</volume>(<issue>3</issue>):
<fpage>697</fpage>–<lpage>709</lpage>.<pub-id pub-id-type="pmid">31652017</pub-id></mixed-citation>
      </ref>
      <ref id="bibr34-13524585211030212">
        <label>34.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Goldberg</surname><given-names>TE</given-names></name>
<name><surname>Harvey</surname><given-names>PD</given-names></name>
<name><surname>Wesnes</surname><given-names>KA</given-names></name>
</person-group>, <etal>et al</etal>. <article-title>Practice effects due to
serial cognitive assessment: Implications for preclinical Alzheimer’s
disease randomized controlled trials</article-title>. <source>Alzheimers
Dement</source>
<year>2015</year>; <volume>1</volume>(<issue>1</issue>):
<fpage>103</fpage>–<lpage>111</lpage>.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
